Remaining Challenges With Transcatheter Left Atrial Appendage Closure

Mohamad Alkhouli, David R. Holmes

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Left atrial appendage closure has emerged as a feasible stroke prevention strategy in selected patients with nonvalvular atrial fibrillation. Since its commercial approval in the United States in 2015, the use of percutaneous left atrial appendage closure has witnessed a substantial growth. However, certain issues remain unresolved with the technology. Knowledge of these issues, their significance, and the current and future efforts to resolve them is key for proper informed decision making by physicians and patients.

Original languageEnglish (US)
Pages (from-to)2244-2248
Number of pages5
JournalMayo Clinic proceedings
Issue number10
StatePublished - Oct 2020

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Remaining Challenges With Transcatheter Left Atrial Appendage Closure'. Together they form a unique fingerprint.

Cite this